Literature DB >> 25622763

Cognitive function is impaired by obesity and alleviated by lorcaserin treatment in mice.

Hong Yang1, Fei Huang, Min Ni, Xin-Bin Zhao, Ya-Ping Deng, Jia-Wen Yu, Guo-Jun Jiang, Xia Tao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25622763      PMCID: PMC6495405          DOI: 10.1111/cns.12381

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  2 in total

1.  Hypothesis: Amelioration of obesity-induced cognitive dysfunction via a lorcaserin-betahistine combination treatment.

Authors:  Ike C Dela Peña; Johnny D Figueroa; Wei-Xing Shi
Journal:  Pharmacol Res Perspect       Date:  2022-06

2.  Lorcaserin Administration Decreases Activation of Brain Centers in Response to Food Cues and These Emotion- and Salience-Related Changes Correlate With Weight Loss Effects: A 4-Week-Long Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Authors:  Olivia M Farr; Jagriti Upadhyay; Anna Gavrieli; Michelle Camp; Nikolaos Spyrou; Harper Kaye; Hannah Mathew; Maria Vamvini; Anastasia Koniaris; Holly Kilim; Alexandra Srnka; Alexandra Migdal; Christos S Mantzoros
Journal:  Diabetes       Date:  2016-07-06       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.